Allotrap 2702
Alternative Names: 2702.75-84; Allotrap TM2702; HLA B2702Latest Information Update: 07 Feb 2001
At a glance
- Originator Stanford University Medical Center
- Class Peptides
- Mechanism of Action Cytotoxic T lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal transplant rejection